buspirone has been researched along with Angioma, Venous, Central Nervous System in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guertin, PA | 1 |
| Brochu, C | 1 |
1 other study available for buspirone and Angioma, Venous, Central Nervous System
| Article | Year |
|---|---|
Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient.
Topics: Adult; Anti-Anxiety Agents; Antiparkinson Agents; Buspirone; Central Nervous System Venous Angioma; | 2009 |